Kirsten Nørgaard 

Professor, Research leader, MD, DMSc, Diabetes Technology Research, Steno Diabetes Center Copenhagen

Email: kirsten.Noergaard@regionh.dk

About Kirsten Nørgaard: Kirsten Nørgaard is Professor, Head of Diabetes Technology Research and Senior Physician  at Steno Diabetes Center Copenhagen. She specializes in the development and optimization of diabetes treatment technologies, focusing on insulin pumps, continuous glucose monitoring (CGM), and algorithm-driven decision support tools to improve diabetes management.

Her research spans several projects, including The StenoTech Study, which investigates predictors for optimal outcome using insulin pump therapy, and ABC Flash, a study comparing the effectiveness of carbohydrate counting apps, bolus calculators, and CGM for pen-treated type 1 diabetes patients. She is also actively involved in closed-loop and open-loop studies, developing and testing automated insulin delivery systems, including dual-hormone artificial pancreas solutions.

Kirsten was also involved in the iPDM-Go project, aimed at designing a digital communication tool to enhance consultations between type 2 diabetes patients and healthcare providers. She has been leading in developing  the Stenopool Platform, which integrate data from insulin pumps, CGMs, and blood glucose meters for improved clinical decision-making, qualityimprovement and research. Additionally, she leads the Ward CGM Project, studying glucose fluctuations in hospitalized patients to develop a real-time alert system for healthcare staff. Further, she is and has been involved in writing several international management guidelines for type 1 treatment.

She collaborates with leading research institutions and hospitals, including DTU Compute, Zealand Pharma, Nordsjællands Hospital Hillerød, Rigshospitalet, and multiple Danish diabetes research centers as well as several international research centers and companies.

Steno Diabetes Center Copenhagen

Steno focuses on cutting-edge diabetes research, divided into Clinical and Translational Research and studies in Prevention, Health Promotion, and Community Care. The Clinical and Translational Research division comprises six research groups investigating clinical epidemiology, complications, diabetes technology, and translational research on both Type 1 and Type 2 diabetes, alongside cardio-metabolic prevention. Research in Prevention, Health Promotion, and Community Care aims to bridge research with real-world health promotion through interdisciplinary collaborations in Denmark and internationally.